Home
>
US Stocks
>
Y-Mabs Therapeutics Inc
Y-Mabs Therapeutics Inc
YMAB

Y-Mabs Therapeutics Inc

$26.018.99%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
26.58
Today Low/High
25.91 / 26.58
52 Week Low/High
$24.78 / $55.22
Market Cap
$1.25B

Company Details

Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The Company has a broad and advanced product pipeline, including one FDA approved product, DANYELZA® (naxitamab-gqgk), which targets tumors that express GD2, and one pivotal-stage product candidate, omburtamab, which targets tumors that express B7-H3.
Organisation
Y-Mabs Therapeutics Inc
Employees
125
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Y-Mabs Therapeutics Inc share price today

Can Indians buy Y-Mabs Therapeutics Inc shares?

How can I buy Y-Mabs Therapeutics Inc shares from India?

Can Fractional shares of Y-Mabs Therapeutics Inc be purchased?

What are the documents required to start investing in Y-Mabs Therapeutics Inc stocks?

We are a SEBI registered investement advisor